Skip to main content

Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J

Publication: Clin Chem (2005) • Vol 51 • Page 973-80PMID: 15845803View on PubMed

Purpose

The purpose of this paper was to determine if blood proteome profiles obtained via magnetic bead fractionation and MALDI-TOF mass spectrometry are impacted by the following preanalytical variables: use and type of anticoagulant, blood clotting time, storage duration and temperature, freeze-thaw cycling.

Conclusion

Serum was superior to plasma specimens for the analysis of the blood proteome. The intensity of protein peaks (range of 1000-10000 m/z) in serum specimens was affected by clotting time, post-centrifugation storage duration and temperature, and freeze-thaw cycling, although effects were molecular size dependent. Significant effects on signal intensity were observed after a clotting time of more than 30 min at room temperature, 1 or more freeze-thaw cycles, storage of centrifuged serum specimens for 120 min or more at room temperature or 30 min or more at 40 degrees C.

Studies (3)

Purpose

The purpose of this study was to compare the quality of protein profiles from serum and plasma obtained with different anticoagulants.

Summary of Findings

Compared to plasma, serum yielded the greater number of protein peaks and higher signal intensities. Among plasma specimens, several peaks observed were anticoagulant-specific.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    ProteinMALDI-TOF MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate
    EDTA
    Heparin
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Platelet-rich plasma
    Serum